Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Acquisition of exclusive commercialization rights for European markets
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
 
        Subscribe To Our Newsletter & Stay Updated